IC
ETNB

Ikarian Capital’s 89bio ETNB Stock Holding History

Ikarian Capital’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100,000
Closed -$727K – 158
2025
Q1 		$727K Buy
+100,000
New +$874K 0.09% 102
2023
Q1 		– Sell
-454,000
Closed -$5.78M – 126
2022
Q4 		$5.78M Buy
454,000
+254,000
+127% +$2.29M 1.39% 24
2022
Q3 		$1.16M Buy
+200,000
New +$879K 0.23% 67
2021
Q1 		– Sell
-32,799
Closed -$799K – 311
2020
Q4 		$799K Sell
32,799
-307,437
-90% -$7.86M 0.04% 181
2020
Q3 		$8.73M Buy
+340,236
New +$10.8M 0.63% 41

Other funds holding ETNB

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ikarian Capital's ETNB Position: Q2 2025 in Review

Ikarian Capital sold out of 89bio (ETNB) in Q2 2025, closing a stake of 100,000 shares — an estimated $727K sold.

Ikarian Capital first reported a position in ETNB in Q3 2020 and held it in 5 quarters. The position peaked at $8.73M in Q3 2020. 184 funds tracked by Wall St. Rank hold ETNB as of Q2 2025.

  • Ikarian Capital reported no remaining 89bio position as of Q2 2025 after selling out during the quarter.
  • Ikarian Capital sold 100,000 89bio shares in Q2 2025, an estimated $727K.
  • Ikarian Capital first reported a position in 89bio in Q3 2020 and held it in 5 quarters.
  • Ikarian Capital's 89bio position peaked at $8.73M in Q3 2020.
  • 184 funds tracked by Wall St. Rank held 89bio as of Q2 2025.

Based on Ikarian Capital's 13F filing for Q2 2025, filed 14 Aug 2025.